Charity Commission updates COVID-19 guidance in relation to charity meetings
The Charity Commission has this month updated its COVID-19 guidance in regard to “AGMs and other meetings: postponing or cancelling meetings”.
Amy Wallhead, a private client solicitor at Hewitsons, has recently trained to be a Dementia Friend Champion and will be delivering four Dementia Friends Sessions at the firms Cambridge office in the coming months.
Amy Wallhead, a private client solicitor at Hewitsons, has recently trained to be a Dementia Friend Champion and will be delivering four Dementia Friends Sessions at the firms Cambridge office in the coming months. Dementia touches the lives of millions of people across the country. Alzheimer’s Society’s Dementia Friends programme is the biggest ever initiative to change people’s perceptions of dementia. It aims to transform the way the nation thinks, talks and acts about the condition as well as tackle the stigma and lack of understanding that means many people with the condition experience loneliness and social exclusion. Dementia Friends is about learning more about dementia and the small ways you can help. From telling friends about the Dementia Friends programme to visiting someone you know living with dementia, every action counts. Each session is free to join and will last approximately 1 hour. To join a session, please click on the relevant link and sign up on the website. Session sizes are limited to 20 people. 30 September 5 October 8 October 19 October Further information: If you would like more information please contact Amy directly by clicking here. Parking: The nearest car park to the venue is the Grafton Centre.
The Charity Commission has this month updated its COVID-19 guidance in regard to “AGMs and other meetings: postponing or cancelling meetings”.
The claimant, who was the tenant under an agreement for lease, sought summary judgment in respect of a notice it had served to terminate the agreement with the defendants (the landlord under the agreement).
Hewitsons is pleased to have supported Medical Research Network Limited (MRN), a market leader in decentralised clinical trials, in successfully completing its recent investment round.